REFERENCES
- Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, et al. Pediatric Oncology Group 9049; Children's Cancer Group 8882. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: A pediatric intergroup study—Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol. 2004; 22: 2691–2700
- Cushing B, Perlman EJ, Marina NM, Castleberry RP. Germ cell tumors. Principles and Practice of Pediatric Oncology, 5 ed., PA Pizzo, DG Poplack. Lippincott Williams & Wilkins, Philadelphia 2006; 1116–1138
- Trigo JM, Tabernero JM, Paz-Ares L, et al. Tumor markers at the time of recurrence in patients with germ cell tumors. Cancer 2000; 88: 162–168
- Flechon A, Culine S, Theodore C, Droz JP. Pattern of relapse after first line treatment of advanced stage germ-cell tumors. Eur Urol. 2005; 48: 957–963
- Morris MJ, Bosl GJ. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors. J Urol. 2000; 163: 796–801
- Wu JT, Book L, Sudar K. Serum α-fetoprotein (AFP) levels in normal infants. Pediatr Res. 1981; 15: 50–52